DLD Asset Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25,000
Closed -$119K 259
2022
Q1
$119K Buy
+25,000
New +$138K 0.01% 200
2019
Q2
Sell
-100,000
Closed -$270K 110
2019
Q1
$270K Buy
+100,000
New +$433K 0.01% 97

Other funds holding IMGN

DLD Asset Management's IMGN Position: Q1 2024 in Review

DLD Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 55,000 shares — an estimated $1.63M sold.

DLD Asset Management first reported a position in IMGN in Q1 2019 and held it in 2 quarters. The position peaked at $3.21M in Q1 2019. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • DLD Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • DLD Asset Management sold 55,000 Immunogen Inc shares in Q1 2024, an estimated $1.63M.
  • DLD Asset Management first reported a position in Immunogen Inc in Q1 2019 and held it in 2 quarters.
  • DLD Asset Management's Immunogen Inc position peaked at $3.21M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on DLD Asset Management's 13F filing for Q1 2024, filed 14 May 2024.